---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-108370"
form_type: "8-K"
ticker: "ABPO"
cik: "0001893219"
company_name: "Abpro Holdings, Inc."
filed_at: "2024-12-12T23:59:59+00:00"
generated_at: "2026-05-29T04:20:02.964028+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Abpro celebrates business combination close; raises $10M and secures $50M equity facility

## Summary
- Business combination with ACAB closed Nov 13, 2024; Nasdaq bell ringing ceremony held Dec 12.
- Raised $10M gross proceeds ($7M PIPE + $2.76M convertible note) and secured up to $50M equity facility from Yorkville.
- Funds to support development of antibody pipeline for HER2+ cancers, wet AMD, DME, and infectious diseases.
- Partnered with Celltrion to advance ABP 102 T-cell engager for HER2+ breast, gastric, pancreatic cancers.

## SEC filing metadata
- accession: 0001213900-24-108370
- form_type: 8-K
- ticker: ABPO
- cik: 0001893219
- company_name: Abpro Holdings, Inc.
- filed_at: 2024-12-12T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1893219/000121390024108370/0001213900-24-108370-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1893219/000121390024108370/ea022449301-8k_abpro.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-108370
- JSON: https://secwatch.observer/filing/0001213900-24-108370.json
- Plain text: https://secwatch.observer/filing/0001213900-24-108370.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.